- +142.9% price growth over the last year
- High gross margin of 90.3%
- Strong return on equity of 139.7%
Cytokinetics stock price up 0.86% on Thursday
(Updated on Jun 18, 2026)
The Cytokinetics stock price gained 0.86% on the last trading day (Thursday, 18th Jun 2026), rising from $78.11 to $78.78. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 3.90% from a day low at $77.14 to a day high of $80.15. The price has risen in 7 of the last 10 days and is up by 8.98% over the past 2 weeks. Volume fell on the last day by -233 thousand shares and in total, 3 million shares were bought and sold for approximately $242.82 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 20.32% during the next 3 months and, with a 90% probability hold a price between $82.31 and $100.15 at the end of this 3-month period.
CYTK Signals & Forecast
The Cytokinetics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $72.85 and $73.58. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 17.46%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Cytokinetics stock
Cytokinetics finds support from accumulated volume at $77.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.01 between high and low, or 3.90%. For the last week, the stock has had daily average volatility of 4.41%.
Since the Cytokinetics has been rising for 6 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.
Our recommended stop-loss: $76.09 (-3.42%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)
Trading Expectations (CYTK) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Cytokinetics to open at $78.69, and during the day (based on 14 day Average True Range), to move between $77.18 and $80.38, which gives a possible trading interval of +/-$3.19 (+/-4.14%) up or down from last closing price. If Cytokinetics takes out the full calculated possible swing range there will be an estimated 4.14% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $77.09, some $1.69 (2.15%) from the current price of $78.78, our system finds the risk reward attractive.
Is Cytokinetics stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Cytokinetics stock to perform well in the short-term.
Current score:
3.881
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 22, 2026 - $78.69 ( 0.114%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CYTK Performance
Trading levels for CYTK
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 81.70 | 3.71% |
| R2 | 80.55 | 2.25% |
| R1 | 79.84 | 1.35% |
| Price | 78.78 | |
| S1 | 77.54 | -1.57% |
| S2 | 76.83 | -2.48% |
| S3 | 75.68 | -3.94% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 78.78 | |
| S1 | 77.09 | -2.15% |
| S2 | 76.91 | -2.37% |
| S3 | 74.29 | -5.70% |
FAQ
Click here for our free guide on how to buy Cytokinetics Stock.
Buy CYTK